← Back to headlines
Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1 Billion
Angelini Pharma has announced its intention to acquire Catalyst Pharmaceuticals for an equity value of $4.1 billion, a move that will expand its portfolio in the pharmaceutical sector.
8 May, 10:06 — 8 May, 10:06
Sources
Showing 1 of 1 sources
